Biological Information

Background Information:

Serotonin 5-HT receptors belong to the superfamily of G protein-coupled seven transmembrane proteins with the exception of the 5-HT3 subtype, which belongs to the ligand gated cation superfamily of receptors. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Serotonin 5-HT2 receptors are widely distributed in the central nervous system and peripheral tissues. The 5-HT2 receptor class couples preferentially to Gq/G11 to increase hydrolysis of inositol phosphates and elevate cytosolic [Ca2+]. Serotonin 5-HT2A receptor agonism may be hallucinogenic, facilitate vasoconstriction and gastrointestinal transit. Receptor antagonism may prevent peripheral vascular thrombosis; reduce psychosis and extrapyramidal side effects of antipsychotic agents.

No. of Assays on Panel:

2

Assays on Panel:

Family

GPCR

Name

Item

355180-0

Protein

5-HT2A

Organism

Human

Assay Sub Type

GTPgammaS

Family

GPCR

Name

Item

355180-1

Protein

5-HT2A

Organism

Human

Assay Sub Type

GTPgammaS

Family:

GPCR

Sub Family:

Serotonin

Class:

Class A

Protein Name:

5-HT2A

Gene Aliases:

5-HT2A

Organism:

Human

Construct Details:

Full Length, Recombinant

Cell Type:

CHO-K1

Assay Information

Assay Type:

Functional

Assay Sub Type:

GTPgammaS

Functional Mode:

Agonist & Antagonist

Detection Method:

Radiometry

Measured Response:

Scintillation

Testing Information

Procedure Summary:

Human recombinant serotonin 5-HT2A receptor stably expressed in CHO-K1 cells is used. Test compound and/or vehicle is preincubated with the membranes and GDP in modified HEPES pH 7.4 buffer for 20 minutes and SPA beads are then added for another 60 minutes at 30°C. The reaction is initiated by [³⁵S]GTPγS for an additional 15 minutes incubation period. Test compound-induced increase of [³⁵S]GTPγS binding by 50 percent or more (≥50%) relative to the 10 µM serotonin response indicates possible serotonin 5-HT2A receptor agonist activity. Test compound-induced inhibition of 1 µM serotonin-induced increase of [³⁵S]GTPγS binding response by 50 percent or more (≥50%) indicates receptor antagonist activity.

Incubation:

15 min at 30°C

Control Activator:

Serotonin (5-HT)

Criteria For Significance:

≥ 50% Increase in bound [35S]GTPgammaS relative to serotonin response, ≥ 50% Inhibition of serotonin-induced bound [35S]GTPgammaS

Test Concentration / Dose:

Compounds are screened at 10, 3, 1, 0.3, 0.1, 0.03, 0.01 and 0.003 μM

Test Sample Requirements:

75 μl of 10 mM stock or 1 mg (pre-weighed) powder (assuming FW ≦500 and purity 100%)

Minimum Order Quantity:

16

Turnaround Time

Standard:

20 Business Days

Reference Compound Data

PubChem ID

5265

Name

Spiperone

Measurement

1.2nM - EC50

PubChem ID

170617

Name

(±)DOI HCl

Measurement

7.1nM - EC50

PubChem ID

90489019

Name

NBOH-2C-CN

Measurement

15nM - EC50

PubChem ID

71433791

Name

TCB-2

Measurement

12nM - EC50

PubChem ID

10071196

Name

Pimavanserin

Measurement

1.5nM - EC50

PubChem ID

160436

Name

Serotonin (5-HT)

Measurement

61nM - EC50

PubChem ID

16219944

Name

Ketanserin

Measurement

1.8nM - EC50

PubChem ID

3039995

Name

Methiothepin

Measurement

0.32nM - EC50

PubChem ID

135456189

Name

SR-46349

Measurement

0.48nM - EC50

PubChem ID

16219944

Name

Ketanserin

Measurement

5.1nM - IC50

Clinical Relevance

Adverse / Beneficial Action:

Serotonin 5-HT1A receptor agonists may be useful for the treatment of anxiety and depression.

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei